These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 25808581)
1. Ablation of human skin mast cells in situ by lysosomotropic agents. Hagforsen E; Paivandy A; Lampinen M; Weström S; Calounova G; Melo FR; Rollman O; Pejler G Exp Dermatol; 2015 Jul; 24(7):516-21. PubMed ID: 25808581 [TBL] [Abstract][Full Text] [Related]
2. Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions. Hagforsen E; Lampinen M; Paivandy A; Weström S; Velin H; Öberg S; Pejler G; Rollman O Br J Dermatol; 2017 Jul; 177(1):179-187. PubMed ID: 28117878 [TBL] [Abstract][Full Text] [Related]
3. Equine Airway Mast Cells are Sensitive to Cell Death Induced by Lysosomotropic Agents. Wernersson S; Riihimäki M; Pejler G; Waern I Scand J Immunol; 2017 Jan; 85(1):30-34. PubMed ID: 27808429 [TBL] [Abstract][Full Text] [Related]
4. Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis. Ma Z; Tovar JP; Kwong KY; Paek D Int Arch Allergy Immunol; 2010; 153(4):413-8. PubMed ID: 20559008 [TBL] [Abstract][Full Text] [Related]
5. Lysosomal membrane permeabilization induces cell death in human mast cells. Melo FR; Lundequist A; Calounova G; Wernersson S; Pejler G Scand J Immunol; 2011 Oct; 74(4):354-62. PubMed ID: 21645032 [TBL] [Abstract][Full Text] [Related]
6. Mast cell apoptosis induced by siramesine, a sigma-2 receptor agonist. Spirkoski J; Melo FR; Grujic M; Calounova G; Lundequist A; Wernersson S; Pejler G Biochem Pharmacol; 2012 Dec; 84(12):1671-80. PubMed ID: 23058984 [TBL] [Abstract][Full Text] [Related]
7. Induction of Human Lung Mast Cell Apoptosis by Granule Permeabilization: A Novel Approach for Targeting Mast Cells. Paivandy A; Sandelin M; Igelström H; Landelius P; Janson C; Melo FR; Pejler G Front Immunol; 2017; 8():1645. PubMed ID: 29230220 [TBL] [Abstract][Full Text] [Related]
8. A New Digital Method for Counting Mast Cells in Cutaneous Specific Lesions of Mastocytosis: A Series of Adult Cases of Mastocytosis With Clinical-Pathological Correlations. Drabent P; Mitri R; Le Naour G; Hermine O; Rossignol J; Molina TJ; Barete S; Fraitag S Am J Dermatopathol; 2021 Jan; 43(1):35-41. PubMed ID: 32568831 [TBL] [Abstract][Full Text] [Related]
9. Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial. Hartmann K; Siebenhaar F; Belloni B; Brockow K; Eben R; Hartmann B; Ruëff F; Schoepke N; Staubach P; Weber A; Maurer M Br J Dermatol; 2010 Jan; 162(1):185-90. PubMed ID: 19785605 [TBL] [Abstract][Full Text] [Related]
11. Mastocytosis: state of the art. Horny HP; Sotlar K; Valent P Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883 [TBL] [Abstract][Full Text] [Related]
12. Mast cells as targets of pimecrolimus. Ma Z; Jiao Z Curr Pharm Des; 2011 Nov; 17(34):3823-9. PubMed ID: 22114844 [TBL] [Abstract][Full Text] [Related]
13. Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis? Georgin-Lavialle S; Le Saché-de Peufeilhoux L; Martin L; Soucie E; Bruneau J; Barete S; Dubreuil P; Bodemer C; Hermine O; Lhermitte L J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):967-71. PubMed ID: 23763569 [TBL] [Abstract][Full Text] [Related]
14. The skin in mastocytosis. Soter NA J Invest Dermatol; 1991 Mar; 96(3 Suppl):32S-38S; discussion 38S-39S, 60S-65S. PubMed ID: 16799606 [TBL] [Abstract][Full Text] [Related]
15. Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway. Lampinen M; Hagforsen E; Weström S; Bergström A; Levedahl KH; Paivandy A; Lara-Valencia P; Pejler G; Rollman O Exp Dermatol; 2022 Nov; 31(11):1729-1740. PubMed ID: 35876458 [TBL] [Abstract][Full Text] [Related]
17. Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling. Chung YL; Pui NN J Dermatol Sci; 2011 Dec; 64(3):163-73. PubMed ID: 21924869 [TBL] [Abstract][Full Text] [Related]
18. Morphological assessment of the effects of cyclosporin A on mast cell--nerve relationship in atopic dermatitis. Toyoda M; Morohashi M Acta Derm Venereol; 1998 Sep; 78(5):321-5. PubMed ID: 9779245 [TBL] [Abstract][Full Text] [Related]
19. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Ostenfeld MS; Fehrenbacher N; Høyer-Hansen M; Thomsen C; Farkas T; Jäättelä M Cancer Res; 2005 Oct; 65(19):8975-83. PubMed ID: 16204071 [TBL] [Abstract][Full Text] [Related]
20. Ultrastructural analysis of human skin biopsy specimens from patients receiving recombinant human stem cell factor: subcutaneous injection of rhSCF induces dermal mast cell degranulation and granulocyte recruitment at the injection site. Dvorak AM; Costa JJ; Monahan-Earley RA; Fox P; Galli SJ J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):793-806. PubMed ID: 9648707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]